First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsMohammad Hojjat‐Farsangi, Ali Moshfegh, Amir Hossein Daneshmanesh et al.|Leukemia|2018Cited by 52
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinibAmir Hossein Daneshmanesh, Håkan Mellstedt, Amineh Ghaderi et al.|PLoS ONE|2018Cited by 43
ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma CellsAmineh Ghaderi, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh et al.|Biomedicines|2020Cited by 38
Effect of ROR1-targeting small molecules on chronic lymphocytic leukemia (CLL) cells.Håkan Mellstedt, Ali Moshfegh, Salam Khan et al.|Journal of Clinical Oncology|2012Cited by 7
First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Ali Moshfegh et al.|Blood|2015Cited by 6